Lv1
30 积分 2025-01-28 加入
TTP488 ameliorates NLRP3‐associated inflammation, viability, apoptosis, and ROS production in an Alzheimer's disease cell model by mediating the JAK1/STAT3/NFκB/IRF3 pathway
3小时前
已完结
Oral ENPP1 inhibitor designed using generative AI as next generation STING modulator for solid tumors
1个月前
已完结
Drug-tolerant persister cells in cancer: the cutting edges and future directions
1个月前
已完结
Bevacizumab in Patients with Nonsquamous Non–Small Cell Lung Cancer and Asymptomatic, Untreated Brain Metastases (BRAIN): A Nonrandomized, Phase II Study
1个月前
已完结
Correlation of EGFR mutation subtypes and survival in surgically treated brain metastasis from non-small-cell lung cancer
2个月前
已完结
Tackling Osimertinib Resistance in EGFR-Mutant Non–Small Cell Lung Cancer
2个月前
已完结
The changing treatment landscape of EGFR-mutant non-small-cell lung cancer
2个月前
已完结
ENPP1 is an innate immune checkpoint of the anticancer cGAMP-STING pathway in breast cancer
4个月前
已完结
169P Immunomodulatory effects of RBS2418, an oral ENPP1 inhibitor in combination with pembrolizumab in checkpoint-refractory metastatic adrenal cancer
7个月前
已关闭
皖公网安备34019202002308
